Jasco Pharmaceuticals, LLC to Present its Preclinical PIM Inhibitor Program at the American Association for Cancer Research Annual Meeting
WOBURN, Mass.--(BUSINESS WIRE)--Jasco Pharmaceuticals, LLC announced that preclinical data on its PIM inhibitor program would be presented at the American Association for Cancer Research (AACR) Annual Meeting to be held on April 2-6, 2011 in Orlando, FL.